| Literature DB >> 36248126 |
Stefanos Voglis1, Yesim Yildiz1, Fabio von Faber-Castell1, Kim Jannis Harnisch2, Luca Regli1, David Bellut1, Rahel Schwotzer3, Menno R Germans1.
Abstract
Introduction: Hereditary transthyretin amyloidosis (ATTRv) is an autosomal-dominant disorder, where a TTR mutations lead to amyloid fibril deposits in tissues and consecutively alter organ function. ATTRv is a multisystemic disorder with a heterogeneous clinical presentation. Spinal leptomeningeal depositions are described only scarcely in the literature. Research question: We present a rare case of surgically treated intradural, extra-medullary amyloidosis with respective clinical, diagnostic and surgical features to raise awareness of this rare entity. Material and methods: Clinical, radiological and operative characteristics were retrieved from the electronical patient management system. Additionally, a scoping literature review on leptomeningeal spinal manifestations of ATTRv was performed.Entities:
Keywords: ATTRv, hereditary transthyretin amyloidosis; EMA, epithelial membrane antigen; Intradural spinal lesion; MRI, magnetic resonance imaging; Operative video; Spinal amyloidosis; Spine surgery; TTR, transthyretin; Thoracic spine; siRNA, small interfering RNA
Year: 2022 PMID: 36248126 PMCID: PMC9560686 DOI: 10.1016/j.bas.2022.100876
Source DB: PubMed Journal: Brain Spine ISSN: 2772-5294
Fig. 4Flow-chart literature review.
Reported cases in the literature with spinal amyloid deposits in hereditary amyloidosis.
| Case | Sex/Age | Symptoms | Diagnosis, level | Mutation | Resection, treatment | Postoperative development | |
|---|---|---|---|---|---|---|---|
| 1 | Mathieu F. et al., 2018 ( | M (53y) | Progressive weakness in upper and lower limbs, ataxia, peripheral and autonomic neuropathy | Oculoleptomeningeal amyloidosis with diffuse leptomeningeal enhancement along the brainstem and spinal cord (plus evidence of hemosiderosis) | p.Ile127Met mutation | T12-L1 laminectomy for biopsy of lesion | n.s. |
| 2 | Nakagawa K. et al., | M (53y) | Recurrent episodes of transient aphasia, stiffness of the right hand, headaches and peripheral neuropathy | Diffuse leptomeningeal amyloidosis from entire cortical sulci to cauda equina | Thr49Pro mutation | Biopsy of superficial cortex and leptomeninges | n.s. |
| 3 | Shimizu, Y. et al., | M (48y) | Intermittent vertigo, dysesthesia in both legs and left hand, inability to walk | Leptomeningeal amyloidosis with linear enhancement from brain surface to cauda equina and demyelinating polyneuropathy | Ala25Thr mutation | Open biopsy at Th11-12 | After 2 years no significant progression of disease and no new areas of weakness or sensory loss |
| 4 | Liu KC J., | F (60y) | Progressively worsening gait imbalance, lower extremity weakness and decreased mental alertness | Oculoleptomeningeal amyloidosis with intrathecal lesion from midcervical to lumbar spine | n.s. | Laminectomy L3-L5, open biopsy of lesion (no attempt of further decompression due to extent of ossification) | n.s. |
| 5 | Jin K. et al., | M (42y) | Unsteady and ataxic gait, dysuria and erectile disorder | Familial leptomeningeal amyloidosis with diffuse leptomeningeal enhancement along sylvian fissures, brainstem, cerebellum and spinal cord | Asp18Gly mutation | Th1 hemilaminectomy and leptomeningeal biopsy | After eight months unsteady gait during several episodes of dull headache, no worsening of neurological findings |
| 6 | McColgan P. et al., | M (43y) | Rapidly progressive neurological decline with erectile difficulties, urinary urgency and incontinence, paresthesias in both feet | Oculoleptomeningeal amyloidosis with extensive leptomeningeal enhancement over surface of brain and spinal cord | Leu12Pro mutation | Brain biopsy | Gradual decline in overall condition and development of atonic bladder |
| 7 | Brett M. et al., 1999 ( | F (38y) | Ascending sensorimotor polyneuropathy, severe autonomic dysfunction with urinary retention and constipation, ataxia | Oculoleptomeningeal amyloidosis and familial amyloid polyneuropathy with leptomeningeal amyloidosis with enhancement of cerebral and spinal meninges | Leu12Pro mutation | Posterior fossa meningeal biopsy | No deterioration, patient died 13 months after the surgery |
| 8 | Herrick M.K. et al., 1996 | F (69y) | Progressive bilateral lower extremity weakness, incontinence, confusion | Familial amyloidotic polyneuropathy (FAP1) with increasing diffuse leptomeningeal and spinal root enhancement from cervical to sacral region | Val30Met mutation | Cerebral cortical biopsy, later dural and frontal lobe meningeal and cortical biopsy | n.s. |
M = male; F = female; y = years; n.s. = not specified.
Fig. 1Pre- and postoperative spine MRI. Pre- (A) and postoperative (B) T2-weighted sagittal (upper) and axial (lower row) MRI series. Asterix (sagittal) and arrowhead (axial section) shows the site of the spinal cord compression.
Fig. 2Intraoperative view. Intraoperative, intradural view before (A) and after (B) resection of the amyloid deposits. After dural opening: (A) shows the glossy white colored amyloid deposit. (B) spinal cord with peri-medullary vessels come into view after complete resection of the lesion.
Fig. 3Histopathological specimen Histological specimen: The biopsy showed scattered connective tissue and predominantly amorphous material. The latter corresponded to amyloid under polarizing light (green) with Kongo Red staining. Scale bar corresponds to 100μm. . (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Previously described mutations associated with leptomeningeal phenotype in general.
| Mutation | Ethnicity | Phenotype | Comment | References | |
|---|---|---|---|---|---|
| 1 | Leu12Pro (p.Leu32Pro) | British | LM, PN, AN, H, L | Included in | |
| 2 | Asp18Gly (p.Asp38Gly) | Hungarian | LM | 56 subjects, no description of location of amyloid deposits and treatment | Vidal (1996) Am J Pathol 148, 361 |
| 3 | Val30Met (p.Val50Met) | American, Chinese, Japanese, European | LM, AN, E, PN | focuses on molecular processes | Saraiva (1984) J Clin Invest 74, 104 |
| 4 | Val30Gly (p.Val50Gly) | American | LM, CNS, E | Not retrieved | Peterson (1997) Ann Neurol 41, 307 |
| 5 | Thr49Pro (p.Thr69Pro) | American | LM, H | Included in | |
| 6 | Gly53Arg (p.Gly73Arg) | American | LM | Brain CT showed diffuse leptomeningeal involvement, no mention of spinal involvement | Liepnieks (2011) Amyloid 18; 1:162 |
| 7 | Gly53Glu (p.Gly73Glu) | French | LM, CNS, N | no involvement of spine described | Ellie (2001), Neurology 57, 135 |
| 8 | Gly53Ala (p.Gly73Ala) | British | LM, AN, E, H, PN | no involvement of spine described | Douglass (2007) J Neurol Neurosurg Psychiatry 78, 193 |
| 9 | Leu55Arg (p.Leu75Arg) | Chinese, German | LM, PN, E | focuses on vitreous amyloidosis | Long (2012) Opthalmic Genet 33(1):28-33 |
| 10 | Phe64Ser (p.Phe84Ser) | Canadian (Italian), British | LM, E, PN, CNS | amyloid in ligamentum flavum led to compression of spinal cord | Uemichi (1999) Arch Neurol 56, 1152 |
| 11 | Ile84Ser (p.Ile104Ser) | Hungarian, Swiss, American | LM, CTS, E, H | postmortem study | Dwulet (1986) J Clin Invest 78, 880 |
| 12 | Tyr114Cys (p.Tyr134Cys) | Japanese | LM, AN, E, H, PN | no involvement of spine described | Ueno (1990) Biochem Biophys Res Commun 169, 143 |
Overview of known TTR mutations causing a leptomeningeal phenotype with the respective references and spinal involvement status. Adapted from http://amyloidosismutations.com/mut-attr.php.
AN = autonomic neuropathy; CTS = carpal tunnel syndrome; E = eye; H = heart; K = kidney; L = liver; LM = leptomeningeal; N = neuropathy; PN = polyneuropathy; CNS = central nervous system.